Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
suspension rectale | est un(e) (attribut) | forme pharmaceutique pour usage rectal (forme pharmaceutique) | true | Inferred relationship | Some | ||
suspension rectale | est un(e) (attribut) | Suspension | false | Inferred relationship | Some | ||
suspension rectale | Has dose form administration method (attribute) | Administer (administration method) | true | Inferred relationship | Some | ||
suspension rectale | Has dose form intended site (attribute) | Rectal (intended site) | true | Inferred relationship | Some | ||
suspension rectale | Has dose form release characteristic (attribute) | Conventional release (release characteristic) | true | Inferred relationship | Some | ||
suspension rectale | Has basic dose form (attribute) | Suspension | true | Inferred relationship | Some | ||
suspension rectale | Has dose form transformation (attribute) | No transformation | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) | a une forme pharmaceutique (attribut) | True | suspension rectale | Inferred relationship | Some | |
Sulfasalazine 30 mg/mL rectal suspension | a une forme pharmaceutique (attribut) | True | suspension rectale | Inferred relationship | Some | |
Bisacodyl 2 mg/mL rectal suspension | a une forme pharmaceutique (attribut) | True | suspension rectale | Inferred relationship | Some | |
Mesalamine 66.7 mg/mL rectal suspension | a une forme pharmaceutique (attribut) | True | suspension rectale | Inferred relationship | Some |
This concept is not in any reference sets